Treasure Chest | 2:40 PM
FNArena's Treasure Chest reports on money making ideas from stockbrokers and other experts. Today's idea is Pro Medicus.
- Brokers reassess Pro Medicus after share price correction
- Quiet period offsets long-term growth momentum and contract wins
- AI, cloud certification, and flagship deployments strengthen outlook
By Danielle Ecuyer
FNArena's Treasure Chest reports on money making ideas from stockbrokers and other experts.
Whose Idea Is It?
Bell Potter
The subject:
Pro Medicus ((PME))
A traditionally quieter period for new contract wins has collided with a souring of sentiment around higher valuation quality companies including Pro Medicus.
More info:
Sentiment and profit-taking are as much a part of the suite of investing variables that can impact share prices as are fundamentals.
Pro Medicus, along with a suite of other high-profile ‘expensive’ (i.e. high valuation price-to-earnings multiples) stocks, has been in the proverbial dog’s box since mid-July when the share price touched an all-time high of $336.
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE